Sudafed Sinus 12 Hour Pressure plus Pain
NDC 50580-434, Naproxen sodium and Pseudoephedrine Hydrochloride, tablet, multilayer, extended release, from Kenvue Brands LLC.
- Product NDC
- 50580-434
- Status
- Listed
- Labeler
- Kenvue Brands LLC
- Dosage form
- TABLET, MULTILAYER, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA076518
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50580-434 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NAPROXEN SODIUM220 mg/1
- PSEUDOEPHEDRINE HYDROCHLORIDE120 mg/1
Pharmacologic classes
Adrenergic alpha-Agonists [MoA]; Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]; alpha-Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50580-434-01 | 50580043401 | 2 BLISTER PACK in 1 CARTON (50580-434-01) / 8 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 50580-434 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50580-434 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50580-434. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.